Dengue and Zika Virus Capsid Proteins Contain a Common PEX19-Binding Motif.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
27 01 2022
Historique:
received: 09 12 2021
revised: 15 01 2022
accepted: 20 01 2022
entrez: 26 2 2022
pubmed: 27 2 2022
medline: 12 3 2022
Statut: epublish

Résumé

Flaviviruses such as dengue virus (DENV) and Zika virus (ZIKV) have evolved sophisticated mechanisms to suppress the host immune system. For instance, flavivirus infections were found to sabotage peroxisomes, organelles with an important role in innate immunity. The current model suggests that the capsid (C) proteins of DENV and ZIKV downregulate peroxisomes, ultimately resulting in reduced production of interferons by interacting with the host protein PEX19, a crucial chaperone in peroxisomal biogenesis. Here, we aimed to explore the importance of peroxisomes and the role of C interaction with PEX19 in the flavivirus life cycle. By infecting cells lacking peroxisomes we show that this organelle is required for optimal DENV replication. Moreover, we demonstrate that DENV and ZIKV C bind PEX19 through a conserved PEX19-binding motif, which is also commonly found in cellular peroxisomal membrane proteins (PMPs). However, in contrast to PMPs, this interaction does not result in the targeting of C to peroxisomes. Furthermore, we show that the presence of C results in peroxisome loss due to impaired peroxisomal biogenesis, which appears to occur by a PEX19-independent mechanism. Hence, these findings challenge the current model of how flavivirus C might downregulate peroxisomal abundance and suggest a yet unknown role of peroxisomes in flavivirus biology.

Identifiants

pubmed: 35215846
pii: v14020253
doi: 10.3390/v14020253
pmc: PMC8874546
pii:
doi:

Substances chimiques

Capsid Proteins 0
Membrane Proteins 0
PEX19 protein, human 157153-79-2

Banques de données

figshare
['10.6084/m9.figshare.c.5811113']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007034
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010315/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010315/2
Pays : United Kingdom

Références

J Mol Biol. 2018 Mar 30;430(7):948-962
pubmed: 29454707
Nat Rev Mol Cell Biol. 2019 Mar;20(3):137-155
pubmed: 30523332
Eur J Cell Biol. 2003 Aug;82(8):401-10
pubmed: 14533738
Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17717-22
pubmed: 16301520
Dis Mon. 2018 May;64(5):235-245
pubmed: 29500061
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3414-9
pubmed: 14993605
Biochim Biophys Acta. 2016 May;1863(5):984-91
pubmed: 26434997
PLoS Pathog. 2018 May 10;14(5):e1007058
pubmed: 29746593
Cell Host Microbe. 2018 Oct 10;24(4):526-541.e7
pubmed: 30269970
Int J Mol Sci. 2019 Aug 08;20(16):
pubmed: 31398956
J Cell Mol Med. 2016 Apr;20(4):750-7
pubmed: 26865163
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2116-21
pubmed: 10051604
J Virol. 2011 Jun;85(11):5571-80
pubmed: 21411523
J Cell Biol. 2001 Jun 11;153(6):1141-50
pubmed: 11402059
J Cell Biol. 2004 Jan 5;164(1):57-67
pubmed: 14709540
Am J Hum Genet. 2000 Oct;67(4):967-75
pubmed: 10958759
PLoS Pathog. 2017 Jun 8;13(6):e1006360
pubmed: 28594894
J Cell Sci. 2006 Jun 15;119(Pt 12):2508-17
pubmed: 16763195
Biochim Biophys Acta. 2016 May;1863(5):922-33
pubmed: 26611709
Virol J. 2017 Feb 21;14(1):35
pubmed: 28222744
Virology. 2017 Feb;502:48-55
pubmed: 27992765
Mol Biol Cell. 2021 Jul 1;32(14):1273-1282
pubmed: 34010015
PLoS Pathog. 2014 Dec 11;10(12):e1004554
pubmed: 25503639
Subcell Biochem. 2013;69:67-75
pubmed: 23821143
J Cell Biol. 1999 Jan 25;144(2):255-66
pubmed: 9922452
Nucleic Acids Res. 2007 Jan;35(Database issue):D815-22
pubmed: 17135190
Trends Cell Biol. 2022 Feb;32(2):124-139
pubmed: 34696946
Cell. 2010 May 14;141(4):668-81
pubmed: 20451243
J Cell Biol. 2004 Mar 15;164(6):863-75
pubmed: 15007061
Sci Rep. 2017 Nov 30;7(1):16652
pubmed: 29192272
Nat Cell Biol. 2016 Jul;18(7):740-51
pubmed: 27295553
Mol Cell Proteomics. 2018 Nov;17(11):2242-2255
pubmed: 30037810
J Biol Chem. 2005 Jun 3;280(22):21176-82
pubmed: 15781447
J Cell Sci. 2010 Oct 1;123(Pt 19):3389-400
pubmed: 20826455
Virology. 2008 Sep 30;379(2):294-305
pubmed: 18684480
Nat Rev Drug Discov. 2017 Aug;16(8):565-586
pubmed: 28473729
Nat Commun. 2017 Mar 10;8:14635
pubmed: 28281558
J Cell Biol. 2008 Dec 29;183(7):1275-86
pubmed: 19114594
Nature. 1995 Jun 1;375(6530):415-8
pubmed: 7760936
Sci Rep. 2016 May 16;6:26028
pubmed: 27181750
Cells. 2019 Jul 15;8(7):
pubmed: 31311201
PLoS Pathog. 2015 Nov 20;11(11):e1005264
pubmed: 26588843
Nat Commun. 2014 Dec 17;5:5790
pubmed: 25517356
Annu Rev Virol. 2016 Sep 29;3(1):263-281
pubmed: 27501261
Biochim Biophys Acta. 2016 May;1863(5):787-9
pubmed: 26851075
Biochem J. 2012 Jun 15;444(3):405-15
pubmed: 22428600
Biochem Biophys Res Commun. 2000 Apr 29;271(1):144-50
pubmed: 10777694
J Virol. 2015 Dec;89(24):12349-61
pubmed: 26423946
Biochem Biophys Res Commun. 2002 Mar 15;291(5):1180-6
pubmed: 11883941
J Virol. 2003 Jun;77(12):7143-9
pubmed: 12768036
PLoS Pathog. 2009 Oct;5(10):e1000632
pubmed: 19851456
Mol Biol Cell. 2004 Jul;15(7):3406-17
pubmed: 15133130
PLoS Negl Trop Dis. 2019 Nov 6;13(11):e0007346
pubmed: 31693659
Gene. 2017 Sep 10;628:117-128
pubmed: 28720531
J Gen Virol. 2008 May;89(Pt 5):1254-1264
pubmed: 18420804

Auteurs

Mafalda A Farelo (MA)

School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.

Despoina Korrou-Karava (D)

School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.

Katrina F Brooks (KF)

School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.

Tiffany A Russell (TA)

School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.

Kevin Maringer (K)

School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.
The Pirbright Institute, Pirbright GU24 0NF, UK.

Peter U Mayerhofer (PU)

School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH